King's spin-out Nuclide Therapeutics secures £5 million investment
£5 million investment in King's biotech spin-out to identify and target therapy-resistant cancers.
£5 million investment in King's biotech spin-out to identify and target therapy-resistant cancers.
A £150 billion technology prosperity deal between the US and the UK was announced during President Donald Trump’s recent state...
The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks...
Leading experts discussed the science, policy and practical approaches to supporting children’s mental health in a digital age.
UK Research and Innovation (UKRI) has today announced the latest recipients of its prestigious Future Leaders Fellowship,...
The proposed legislation that would give terminally ill adults in England and Wales the right to be provided with assistance to...
In this Spotlight on Arts & Humanities, we detail the project that details what connects people across millennia — the search...
Dr Ylva Baeckström’s research highlights how gender stereotypes affect women, both as consumers of financial advice and as...
For people living at home with advanced illness, health can worsen rapidly and unpredictably. This makes it essential that they...
As part of our Spotlight on Arts & Humanities series we delve into the Making Sense of Visual Art — a project led by classicist,...
Type 2 diabetes is among one of the foremost challenges facing policymakers in Thailand. It accounts for considerable death,...
In the latest Spotlight on Arts & Humanities, we look at how a project from the Department of Classics is helping preserve world...
Providing information and resources for journalists and media professionals.